Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
Product Unit Size | Cost | Quantity | Stock |
---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
Cas No. | 1258595-14-0 |
---|---|
Purity | ≥99% |
Formula | C29H32F2N3O7P |
Formula Wt. | 603.56 |
IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
Synonym | LHC165 |
Appearance | Pale yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Used to prevent chromium deficiency and to decr...
Phenolic phytoalexin found in soy, grapes, and ...
Endogenous peptide hormone, involved in cell gr...
Triterpenoid
Derivative of methyl caffeate, hydroxycinnamic ...
Cannabinoid receptor 2 selective agonist.
Hydroxycinnamic acid found in various plant sou...
Proteasome antigen.
Antimicrobial found in essential oils from plan...
Endogenous peptide, produced by activation of P...
pan-Bcr-Abl tyrosine kinase inhibitor.
Indoloquinazoline alkaloid found in Evodia; COX...
Endogenous peptide hormone fragment, involved i...
Cap-dependent endonuclease inhibitor
5-Aminosalicylate prodrug, NSAID; COX-1/2 inhib...
Nitroimidazole, binds DNA; nucleic acid synthes...
An omega-3 fatty acid.
ACE inhibitor.
Found in Aristolochia and Radix; potential PLA2...
γ-Secretase inhibitor.